Israel Canada Hotels Ltd
ICHO
Israel Canada Hotels Ltd, operating through its various subsidiaries, is... Israel Canada Hotels Ltd, operating through its various subsidiaries, is globally involved in the creation, production, and distribution of patented ultrasound technology. These advanced systems are instrumental in assessing bone strength and density, alongside tracking calcium loss, especially for diagnosing osteoporosis in both adults and children. Beyond its medical device activities, the company also engages in the development of oral pharmaceuticals. Incorporated in 2004 and based in Tel Aviv, Israel, the entity, which was previously known as Dna Group (T.R.) Ltd, is set to formally adopt the name Israel Canada Hotels Ltd in November 2025.
